Internal Medicine Alert – May 15, 2017
May 15, 2017
View Issues
-
Considering More Intensive Blood Pressure Control in the Elderly
In elderly, hypertensive patients, intensive blood pressure (BP) control (systolic BP < 140 mmHg) decreased major adverse cardiovascular events, including cardiovascular mortality and heart failure.
-
Treating Erectile Dysfunction After Myocardial Infarction May Be Safe
In a Swedish nationwide cohort study of men < 80 years of age hospitalized for myocardial infarction, treatment for erectile dysfunction with phosphodiesterase-5 inhibitors resulted in lower mortality and heart failure hospitalization.
-
A New Risk Score for Stroke in Atrial Fibrillation
A new, simpler score for stroke risk prediction in atrial fibrillation patients uses biomarkers to supplant many clinical variables and outperforms the CHA2DS2-VASc score in two large cohorts.
-
Ocrelizumab Injection (Ocrevus)
Ocrelizumab is indicated for the treatment of patients suffering from relapsing multiple sclerosis or primary progressive multiple sclerosis.
-
Clinical Briefs
In this section: treating depression; the subdural risk of antithrombotics; and the health consequences of a poor diet.
-
Is This Fascicular Ventricular Tachycardia?
The ECG in the figure in this story was obtained from a 55-year-old man who presented for emergency care with palpitations and fatigue. His blood pressure was 80/50 mmHg at the time the tracing was recorded. Is this a case of ventricular tachycardia?